↓ Skip to main content

Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties

Overview of attention for article published in Frontiers in oncology, January 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties
Published in
Frontiers in oncology, January 2022
DOI 10.3389/fonc.2021.808300
Pubmed ID
Authors

Jimin Park, Seung Ki Kim, Steffanus Pranoto Hallis, Bo-Hyun Choi, Mi-Kyoung Kwak

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 24%
Student > Ph. D. Student 2 12%
Unspecified 2 12%
Researcher 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 7 41%
Readers by discipline Count As %
Unspecified 2 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 12%
Biochemistry, Genetics and Molecular Biology 2 12%
Medicine and Dentistry 2 12%
Materials Science 1 6%
Other 1 6%
Unknown 7 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2022.
All research outputs
#23,487,873
of 26,166,431 outputs
Outputs from Frontiers in oncology
#16,355
of 22,913 outputs
Outputs of similar age
#455,457
of 531,363 outputs
Outputs of similar age from Frontiers in oncology
#908
of 1,442 outputs
Altmetric has tracked 26,166,431 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 531,363 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,442 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.